Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joan Maurel

Showing results (51-60 of 116) with videos related to

Pageof 12
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 2, 2007
Open-label phase III trial of panitumumab plus best supportive care compared with best supportive care alone in patients with chemotherapy-refractory metastatic colorectal cancerEric Van Cutsem, Marc Peeters, Salvatore Siena, et al.
Cancer Chemotherapy and Pharmacology|March 13, 2008
Cisplatin plus weekly CPT-11/docetaxel in advanced esophagogastric cancer: a phase I study with pharmacogenetic assessment of XPD, XRCC3 and UGT1A1 polymorphismsAlbert Font, Ramon Salazar, Joan Maurel, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 24, 2005
Irinotecan in combination with fluorouracil in a 48-hour continuous infusion as first-line chemotherapy for elderly patients with metastatic colorectal cancer: a Spanish Cooperative Group for the Treatment of Digestive Tumors studyJavier Sastre, Eugenio Marcuello, Bartomeu Masutti, et al.
International Journal of Cancer|May 10, 2007
Serum matrix metalloproteinase 7 levels identifies poor prognosis advanced colorectal cancer patientsJoan Maurel, Cristina Nadal, Xabier Garcia-Albeniz, et al.
Cancer Medicine|October 16, 2023
Efficacy and safety of abemaciclib alone and with PI3K/mTOR inhibitor LY3023414 or galunisertib versus chemotherapy in previously treated metastatic pancreatic adenocarcinoma: A randomized controlled trialE Gabriela Chiorean, Vincent Picozzi, Chung-Pin Li, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|February 7, 2026
SEOM-GEMCAD-TTD clinical guidelines for anal cancer (2025)Mónica Guillot Morales, Ana Fernández Montes, Julen Fernández-Plana, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|October 27, 2010
SEOM clinical guidelines for the adjuvant treatment of colorectal cancerCristina Grávalos Castro, Joan Maurel Santasusana, Fernando Rivera Herrero, et al.
Investigational New Drugs|March 13, 2018
Phase II trial of ifosfamide in combination with the VEGFR inhibitor sorafenib in advanced soft tissue sarcoma: a Spanish group for research on sarcomas (GEIS) studyXavier García Del Muro, Joan Maurel, Javier Martínez Trufero, et al.
Lancet (London, England)|June 3, 2008
Efficacy of gemcitabine plus axitinib compared with gemcitabine alone in patients with advanced pancreatic cancer: an open-label randomised phase II studyJean-Philippe Spano, Catherine Chodkiewicz, Joan Maurel, et al.
Pancreatology : Official Journal of the International Association of Pancreatology (IAP) ... [Et Al.]|August 29, 2017
Endoscopic ultrasonography can avoid unnecessary laparotomies in patients with pancreatic adenocarcinoma and undetected peritoneal carcinomatosisNadia Alberghina, Cristina Sánchez-Montes, Carlos Tuñón, et al.
Pageof 12

Showing results (51-60 of 116) with videos related to

Sort By:
Pageof 12
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 2, 2007
Open-label phase III trial of panitumumab plus best supportive care compared with best supportive care alone in patients with chemotherapy-refractory metastatic colorectal cancerEric Van Cutsem, Marc Peeters, Salvatore Siena, et al.
Cancer Chemotherapy and Pharmacology|March 13, 2008
Cisplatin plus weekly CPT-11/docetaxel in advanced esophagogastric cancer: a phase I study with pharmacogenetic assessment of XPD, XRCC3 and UGT1A1 polymorphismsAlbert Font, Ramon Salazar, Joan Maurel, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 24, 2005
Irinotecan in combination with fluorouracil in a 48-hour continuous infusion as first-line chemotherapy for elderly patients with metastatic colorectal cancer: a Spanish Cooperative Group for the Treatment of Digestive Tumors studyJavier Sastre, Eugenio Marcuello, Bartomeu Masutti, et al.
International Journal of Cancer|May 10, 2007
Serum matrix metalloproteinase 7 levels identifies poor prognosis advanced colorectal cancer patientsJoan Maurel, Cristina Nadal, Xabier Garcia-Albeniz, et al.
Cancer Medicine|October 16, 2023
Efficacy and safety of abemaciclib alone and with PI3K/mTOR inhibitor LY3023414 or galunisertib versus chemotherapy in previously treated metastatic pancreatic adenocarcinoma: A randomized controlled trialE Gabriela Chiorean, Vincent Picozzi, Chung-Pin Li, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|February 7, 2026
SEOM-GEMCAD-TTD clinical guidelines for anal cancer (2025)Mónica Guillot Morales, Ana Fernández Montes, Julen Fernández-Plana, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|October 27, 2010
SEOM clinical guidelines for the adjuvant treatment of colorectal cancerCristina Grávalos Castro, Joan Maurel Santasusana, Fernando Rivera Herrero, et al.
Investigational New Drugs|March 13, 2018
Phase II trial of ifosfamide in combination with the VEGFR inhibitor sorafenib in advanced soft tissue sarcoma: a Spanish group for research on sarcomas (GEIS) studyXavier García Del Muro, Joan Maurel, Javier Martínez Trufero, et al.
Lancet (London, England)|June 3, 2008
Efficacy of gemcitabine plus axitinib compared with gemcitabine alone in patients with advanced pancreatic cancer: an open-label randomised phase II studyJean-Philippe Spano, Catherine Chodkiewicz, Joan Maurel, et al.
Pancreatology : Official Journal of the International Association of Pancreatology (IAP) ... [Et Al.]|August 29, 2017
Endoscopic ultrasonography can avoid unnecessary laparotomies in patients with pancreatic adenocarcinoma and undetected peritoneal carcinomatosisNadia Alberghina, Cristina Sánchez-Montes, Carlos Tuñón, et al.
Pageof 12